Methods and compositions for intraocular administration to treat ocular conditions
作者： John T. Trogden , Robert T. Lyons , Scott M. Whitcup , James N. Chang
DOI:
关键词:
摘要: Anti-angiogenesis compositions, and methods of using such useful for injection into the vitreous human eyes are provided. Such compositions can include TKI component solutions or particles present in a therapeutically effective amount, viscosity inducing component, an aqueous carrier component. The have viscosities at about 25° C. least 10 cps 100 shear rate 0.1/second. In preferred embodiment, is range from 80,000 to 300,000 cps.
google.co.in 参考文章(167)
Glenn T. Miller, Barry Jones, Michael I. Jesson, Sharlene Adams, Methods and compositions relating to isoleucine boroproline compounds ,(2003)
Rainer Munschauer, David Calderwood, Paul Rafferty, Gavin C. Hirst, David N. Johnston, Lee D. Arnold, Pyrrolopyrimidines as therapeutic agents ,(2000)
Elena Dneprovskaia, Wolfgang Wrasidlo, Heterocyclic compounds and methods of use ,(2005)
Walter Morozowich, Malcolm Wilson Moon, Peng Cho Tang, Ping Gao, Mannich base prodrugs of 3-(Pyrrol-2-yl-methylidene)-2-indolinone derivatives ,(2003)
Venkata Rami Reddy Macherla, Barbara Christine Potts, Michael Palladino, Saskia Theodora Cornelia Neuteboom, Methods of using [3.2.0] heterocyclic compounds and analogs thereof ,(2006)
Mien-Chie Hung, Yan Li, Yong Wen, Antitumor effect of mutant Bik ,(2004)
Janis Haimichael, Istvan Szekely, Fairooz F. Kabbinavar, Tamas Bajor, Gyorgi Keri, Reiner Lammers, Aviv Gazit, Alex Levitzki, Laura Kay Shawver, Klaus Peter Hirth, Laszlo Orfi, Elaina Mann, Dennis Slamon, Donna Pruess Schwartz, Peng Cho Tang, Axel Ullrich, Treatment of platelet derived growth factor related disorders such as cancers ,(1995)
Wayne Daniel Klohs, Alexander James Bridges, Denise Driscoll, N-[4-(3-chloro-4-fluoro-phenylamino)-7-(3-morpholin-4-yl-propoxy)-quinazolin-6-yl]-acrylamide, an irreversible inhibitor of tyrosine kinases ,(1999)
Arthur H. Neufeld, Bin Liu, Methods of treatment of glaucoma and other conditions mediated by nos-2 expression via inhibition of the egfr pathway ,(2003)
John T. Trogden, Gerald W. Devries, Robert T. Lyons, Scott M. Whitcup, Patrick M. Hughes, High viscosity macromolecular compositions for treating ocular conditions ,(2008)